ApprovalTrail

Approval · Notice of Compliance 7672 · 2005

LINCOMIX 100 INJECTABLE SOLUTION: Notice of Compliance 7672

Issued December 29, 2005

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7672
Date
December 29, 2005
Company
Pfizer Canada Inc., Animal Health GroupKirkland, Quebec, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Antibiotic

Products in this notice

BrandDINStatus today
LINCOMIX 100 INJECTABLE SOLUTION00813745Marketed

Medicinal ingredients